Description
Point-of-Care Diagnostics Market Outlook 2025 to 2034
The global Point-of-Care Diagnostics market is valued at approximately $15.59 billion in 2024, an estimated $59.69 billion in 2025, and is projected to reach around $129.88 billion by 2034, growing at a CAGR of 9.04% from 2025 to 2034. This rapid growth can be attributed to the advantages offered by Point-of-Care Diagnostics, such as faster results, reduced turnaround times, and improved patient outcomes.
One of the key drivers of the Point-of-Care Diagnostics market is the rising demand for decentralized testing solutions. With Point-of-Care Diagnostics, healthcare providers can quickly diagnose conditions such as infections, cardiovascular diseases, and diabetes, enabling them to make timely treatment decisions. This decentralized approach not only improves patient care but also helps to reduce the burden on centralized laboratories, leading to cost savings for healthcare systems.
In addition to the clinical benefits, Point-of-Care Diagnostics also offers economic advantages. By enabling healthcare providers to make faster diagnoses and treatment decisions, Point-of-Care testing can help to reduce hospital admissions, decrease the length of hospital stays, and lower overall healthcare costs. This cost-effectiveness has been a driving factor in the widespread adoption of Point-of-Care Diagnostics across various healthcare settings.
Overall, the market for Point-of-Care Diagnostics is poised for continued growth, fueled by advancements in technology, increasing investment in research and development, and the growing demand for rapid and accurate diagnostic solutions. With its ability to deliver quick and reliable results, Point-of-Care Diagnostics is revolutionizing the way healthcare is delivered, providing patients with better outcomes and healthcare providers with valuable tools to improve decision-making processes.
Explore Key Insights
- Analyzes Point-of-Care Diagnostics market trends, forecasts, and regional dynamics
- Covers core offerings, innovations, and industry use cases
- Profiles major players, value chains, and strategic developments
- Highlights innovation trends, regulatory impacts, and growth opportunities
Point-of-Care Diagnostics Market Dynamics
Drivers
The increasing prevalence of infectious diseases, growing demand for personalized medicine, and the rising geriatric population are driving the growth of the point-of-care diagnostics market. The need for rapid and accurate testing in remote locations, such as rural areas or developing countries, is also fueling the demand for portable and easy-to-use diagnostic devices.
Restraints
One of the main challenges facing the point-of-care diagnostics market is the high cost of these devices compared to traditional laboratory tests. Additionally, the lack of standardized regulations for these devices can hinder their widespread adoption. Furthermore, the limited sensitivity and specificity of some point-of-care tests may raise concerns about their accuracy and reliability.
Challenges
Ensuring the accuracy and reliability of point-of-care diagnostic tests poses a significant challenge for manufacturers. The integration of new technologies, such as artificial intelligence and machine learning, into these tests also presents technical hurdles. Moreover, educating healthcare professionals and patients about the benefits of point-of-care testing is crucial for overcoming resistance to change.
Opportunities
Despite the challenges, the point-of-care diagnostics market offers numerous opportunities for growth and innovation. Advances in miniaturization and automation technologies are creating new possibilities for developing faster and more efficient diagnostic devices. The increasing focus on preventive healthcare and early disease detection is driving the demand for point-of-care testing, opening up opportunities for market expansion.
List of Key Players
- Abbott Laboratories
- Roche Diagnostics
- Siemens Healthineers
- Danaher Corporation
- BD (Becton, Dickinson and Company)
- bioMérieux
- QuidelOrtho Corporation
- Bio-Rad Laboratories
- Chembio Diagnostics
- Thermo Fisher Scientific
- EKF Diagnostics
- Instrumentation Laboratory (Werfen)
- Nova Biomedical
- Trinity Biotech
- Sekisui Diagnostics
- PTS Diagnostics
- OraSure Technologies
- Cue Health
- Sight Diagnostics
- LumiraDx
Recent Developments:
Abbott Laboratories – May 2025: Abbott launched the ID NOW™ 2.0, an upgraded version of its rapid molecular POC testing platform, offering faster turnaround and broader disease detection.
QuidelOrtho – March 2025: Announced the U.S. FDA 510(k) clearance for the Sofia® 3 SARS Antigen FIA, enhancing its rapid COVID-19 and influenza POC diagnostics line.
Siemens Healthineers – January 2025: Launched Atellica VTLi Patient-Side Immunoassay Analyzer in key Asian markets, enabling cardiac troponin testing in emergency settings.
Cue Health – August 2024: Received CE marking for its Cue Mpox Test, a molecular point-of-care test for monkeypox, expanding its infectious disease test portfolio.
Point-of-Care Diagnostics Market Segmentation
By Product Type:
- Glucose Monitoring Kits
- Cardiometabolic Monitoring Kits
- Infectious Disease Testing Kits
- Pregnancy and Fertility Testing Kits
- Hematology Testing Kits
- Coagulation Testing Kits
- Urinalysis Testing Kits
- Cholesterol Test Strips
- Tumor/Cancer Markers Test Kits
By Technology:
- Lateral Flow Assays
- Immunoassays
- Molecular Diagnostics
- Microfluidics
- Dipsticks
- Biosensors
By Mode of Prescription:
- Prescription-based Testing
- Over-the-counter (OTC) Testing
By End-User:
- Hospitals & Clinics
- Diagnostic Laboratories
- Home Care Settings
- Research Laboratories
- Ambulatory Care Facilities
By Sample Type:
- Blood
- Urine
- Saliva
- Nasal/Throat Swab
- Others
Regional Market Insights: A Breakdown by Region
North America: Leading the Way in Adoption
North America leads the global market in the adoption of Point-of-Care Diagnostics. The region’s well-established healthcare infrastructure and increasing prevalence of chronic diseases have fueled the demand for rapid diagnostic tests. With a strong focus on technological innovation, North American countries are investing heavily in Point-of-Care testing devices, driving market growth in the region.
Europe: Embracing Point-of-Care Solutions
Europe is also embracing Point-of-Care Diagnostics, with countries like Germany, the UK, and France at the forefront of innovation. The rising geriatric population and the need for early detection of infectious diseases have propelled the demand for rapid diagnostic tests in the region. European regulatory bodies are actively promoting the adoption of Point-of-Care solutions, further driving market growth.
Asia Pacific: Emerging as a Key Market
The Asia Pacific region is emerging as a key market for Point-of-Care Diagnostics, driven by the increasing healthcare expenditure and growing awareness about the benefits of rapid diagnostic tests. Countries like China, India, and Japan are investing in healthcare infrastructure and technology, fueling market growth. The need for quick and accurate diagnostic tests in remote and rural areas has also accelerated the adoption of Point-of-Care solutions in the region.
Latin America: Addressing Healthcare Disparities
Latin America is gradually adopting Point-of-Care Diagnostics to address healthcare disparities and improve access to quality healthcare services. The region’s healthcare challenges, such as limited resources and geographical barriers, have created a demand for rapid diagnostic tests that can be easily deployed in remote settings. Governments and healthcare organizations in Latin America are increasingly investing in Point-of-Care technologies to enhance patient care and outcomes.
Middle East and Africa: Overcoming Healthcare Challenges
In the Middle East and Africa, Point-of-Care Diagnostics is playing a crucial role in overcoming healthcare challenges and improving patient outcomes. The region’s burden of infectious diseases, limited access to healthcare facilities, and shortage of trained medical professionals have created a need for rapid and accurate diagnostic tests. Point-of-Care solutions are providing healthcare providers with the tools they need to diagnose and treat patients in a timely manner, ultimately saving lives and improving overall healthcare outcomes.
Target Audience
Hospitals and Emergency Departments
Primary Care Physicians and Clinics
Diagnostic Laboratories
Home Healthcare Providers
Retail Pharmacies
Nursing Homes and Long-Term Care Facilities
Public Health Authorities
Medical Device Distributors
Investors and Venture Capital Firms
Healthcare IT and Software Companies
Government and Regulatory Bodies
Non-Governmental Health Organizations
Academic and Research Institutions
Corporate Health Programs
Mobile Health (mHealth) Providers
Reasons to Purchase this Report:
- Comprehensive qualitative and quantitative analysis of the market, incorporating both economic and non-economic factors across all segmentation dimensions.
- Providing of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Geographical analysis detailing regional consumption patterns of the product/service, along with key factors influencing market dynamics within each region.
- Competitive landscape analysis including market ranking of key players, along with recent developments such as new product/service launches, partnerships, business expansions, and acquisitions over the past five years for the profiled companies.
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market companies
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes a detailed analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
